Literature DB >> 22524973

Characteristics of stroke mechanisms in patients with medullary infarction.

M J Lee1, Y G Park, S J Kim, J J Lee, O Y Bang, J S Kim.   

Abstract

BACKGROUND: Few studies have focused on the mechanisms underlying medullary infarctions. Our aim in this study was to investigate stroke mechanisms in patients with medullary infarctions and to determine the clinical, radiological and laboratory characteristics of these patients with different underlying stroke etiologies.
METHODS: Consecutive patients with medullary infarction were analysed. Stroke mechanisms were classified as large artery disease (LAD), cardiogenic embolism (CE), small vessel disease (SVD), arterial dissection or undetermined etiology. Clinical, radiological and laboratory factors were analysed according to the location of the lesion and stroke mechanisms.
RESULTS: A total of 77 patients were enrolled in this study. Amongst them, 53 (68.8%) patients had lateral medullary infarction (LMI), 22 (28.6%) had medial medullary infarction (MMI), and the remaining 2 (2.6%) had hemimedullary infarction. In both LMI and MMI patients, LAD was the most frequently encountered stroke mechanism. Arterial dissection was the second most common cause followed by SVD and CE in patients with LMI, whereas SVD was more frequently observed (P < 0.001) and dissection and CE were less prevalent (P < 0.001 and P = 0.024, respectively) in MMI than in LMI. Regarding differences amongst stroke etiologies, patients with dissection were younger and had a significantly lower incidence of metabolic syndrome (P = 0.002 and P = 0.009, respectively) than patients with LAD and SVD. Patients in the LAD (19/34, 60%) and dissection groups (12/14, 75%) had abnormal perfusion-weighted MRI (PWI) findings, whereas all patients with SVD (9/9) had normal PWI findings (P < 0.001).
CONCLUSIONS: Stroke mechanisms in medullary infarction differ between LMI and MMI. Clinical and radiological characteristics, especially PWI features, are helpful in discriminating the etiologies of stroke in these patients.
© 2012 The Author(s) European Journal of Neurology © 2012 EFNS.

Entities:  

Mesh:

Year:  2012        PMID: 22524973     DOI: 10.1111/j.1468-1331.2012.03722.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  7 in total

Review 1.  Lateral medullary infarction with cardiovascular autonomic dysfunction: an unusual presentation with review of the literature.

Authors:  Tridu R Huynh; Barbara Decker; Timothy J Fries; Ajay Tunguturi
Journal:  Clin Auton Res       Date:  2018-01-24       Impact factor: 4.435

2.  Double conduction through the atrioventricular node following acute medullary infarction: a case report.

Authors:  Salem A Salem; Nadish Garg; Raed Abu Shama; Sunil Jha; Showkat Haji; Muhammed Shahreyar; Devarshi Ardeshna
Journal:  Ann Transl Med       Date:  2018-01

3.  Clinical and radiological features of medullary infarction caused by spontaneous vertebral artery dissection.

Authors:  Weijun Tang; Xiang Han; Chun Yu; Zhu Zhu; Siying Li; Yi Xu; Wei Yan; Xiaocui Kang; Yao Li; Qiang Dong
Journal:  Stroke Vasc Neurol       Date:  2022-03-03

4.  Lesion Topography and Its Correlation With Etiology in Medullary Infarction: Analysis From a Multi-Center Stroke Study in China.

Authors:  Yue-Hui Hong; Li-Xin Zhou; Ming Yao; Yi-Cheng Zhu; Li-Ying Cui; Jun Ni; Bin Peng
Journal:  Front Neurol       Date:  2018-09-27       Impact factor: 4.003

5.  Undiagnosed polycythemia, an uncommon cause of Wallenberg syndrome: A case report.

Authors:  Aadesh Rayamajhi; Biraj Pokhrel; Shambhu Khanal; Anjan Shrestha
Journal:  Clin Case Rep       Date:  2022-04-20

6.  Dysphagia caused by a lateral medullary infarction syndrome (Wallenberg's syndrome).

Authors:  Amine El Mekkaoui; Hanane Irhoudane; Adil Ibrahimi; Mounia El Yousfi
Journal:  Pan Afr Med J       Date:  2012-07-31

Review 7.  Diagnosis of Intracranial Artery Dissection.

Authors:  Masafumi Kanoto; Takaaki Hosoya
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-05-13       Impact factor: 1.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.